mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
0.0005 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |